Organisation paid for research Program year 2025 Source: CMS Open Payments

Advantage Clinical Trials Corp

Neither a doctor nor a teaching hospital

Research payments

$1,654,106

76 payments

Through program year 2025, Advantage Clinical Trials Corp is reported as receiving $1,654,106 in research payments, across 76 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$738,950	29
2024	Research	$714,933	26
2022	Research	$4,098	4
2021	Research	$17,710	7
2020	Research	$1,650	1
2019	Research	$176,765	9

Breakdown

Who paid Research payments · program years 2019–2025

Genentech, Inc. $1,399,094 44 payments
Ironwood Pharmaceuticals, Inc $176,765 9 payments
ITI, Inc. $29,000 3 payments
Sanofi Pasteur Inc. $21,100 10 payments
GlaxoSmithKline, LLC. $16,658 3 payments
AbbVie, Inc. $11,489 7 payments

Studies the money was for Research payments · program years 2019–2025

Roche Cancer Screening Collection Study $1,399,094 44 payments
C3718-302 $176,765 9 payments
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers $21,100 10 payments
Iti-007-321 $15,500 2 payments
A Phase 2, Randomized, Double-Blind, Multi-Dose, Dose Finding Study to $14,300 1 payment
Iti-007-602 $13,500 1 payment
Linaclotide Safety and Efficacy in Pediatric Participants 6 to 17 Years of Age With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) $9,708 6 payments
A Phase II, Observer-Blind, Randomized, Controlled Study to Evaluate T $2,358 2 payments
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) $1,781 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.